CDC backs boosters for high-risk kids aged 5-11, shorter time between shots

(HealthDay)—The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer’s booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period between a second dose and a booster shot from six months to five months. Both approvals came from the U.S. Food and Drug Administration on […]
Continue reading »